ABSTRACT Background: Inverse associations between dairy intake and the risk of type 2 diabetes have been shown, but more studies are needed, especially from low-and middle-income countries. Objective: The objective was to describe the association between dairy products and direct measures of glycemic status in adults without known diabetes. Design: The Brazilian Longitudinal Study of Adult Health (ELSABrasil) includes 15,105 adults, aged 35-74 y, enrolled from universities and research institutions in 6 Brazilian capital cities. We excluded participants with a known diabetes diagnosis, cardiovascular diseases, and cancer. Dairy consumption was assessed by a food-frequency questionnaire, and we computed servings per day for total and subgroups of dairy. Associations with fasting blood glucose (FG) and fasting insulin, 2-h postload glucose (PG), 2-h postload insulin (PI), glycated hemoglobin (Hb A 1c ), and homeostasis model assessment of insulin resistance (HOMA-IR) were assessed through multivariable linear regression analysis with adjustment for demographic characteristics, behavioral risk factors, other dietary factors, and anthropometric measurements. Results: The sample size after exclusions was 10,010. The intake of total dairy was inversely associated with FG (linear b for dairy servings/d = 20.46 6 0.2 mg/dL), PG (21.25 6 0.5 mg/dL), PI (21.52 6 0.6 mg/dL), Hb A 1c (20.02 6 0.0%), and HOMA-IR (20.04 6 0.0) after adjustment for all covariates (P , 0.05 for all). The findings were consistent across categories of sex, race, obesity status, and dairy fat amount (reduced-fat vs. full-fat dairy). Fermented dairy products showed particularly strong inverse associations with the outcomes, with adjusted differences for a 1-serving/ d increment of 20.24 (95% CI: 20.46, 20.02) mg/dL for FG, 20.86 (21.42, 20.30) mg/dL for PG, and 20.01% (20.02%, 0.00%) for Hb A 1c . Myristic acid was the only nutrient that appeared to mediate the association between dairy intake and glycemia. Conclusion: Dairy intake, especially fermented dairy, was inversely associated with measures of glycemia and insulinemia in Brazilian adults without diagnosed diabetes. This trial was registered at clinicaltrials.com as NCT02320461.
INTRODUCTION
The number of people with diabetes in the world is projected to increase from 382 million in 2013 to 592 million by 2035, with 80% of cases occurring in low-and middle-income countries (1) . Diet has been associated with the development of diabetes, and lifestyle changes can reduce the incidence of type 2 diabetes (T2D) 5 (2) . However, there remains a need for improved scientific insight on the effects of dietary composition and specific food groups on the risk of T2D.
Dairy product consumption has been inversely associated with incident T2D risk. Recently, a meta-analysis estimated a reduction in T2D risk of 7-14% with increased dairy intake (3, 4) . However, the results for subgroups of dairy (e.g., milk, cheese, yogurt) were inconclusive because of more limited data as well as the potential for residual confounding (5, 6) .
There are few studies on dairy and diabetes risk from developing countries. In Brazil, although dairy intake is common (7, 8) , it has recently been in decline, whereas the prevalence of diabetes has been increasing (9) . Data from the household budget survey on food and beverages in Brazil suggest a decline in dairy consumption across all socioeconomic strata compared with the 2002-2003 and 2008-2009 surveys. Still, per capita estimates show that total dairy remains one of the most commonly consumed food groups in Brazil (8) . In consideration of the increased risk of T2D and the relevant consumption of dairy products in Brazil, the purpose of the present study was to describe the association between dairy product intake, and subgroups of dairy, with diabetes risk in Brazilian adults.
METHODS

Study design
The Brazilian Longitudinal Study of Adult Health [Estudo Longitudinal de Saúde do Adulto (ELSA)-Brasil; registered at clinicaltrials.com as NCT02320461] is a multicenter cohort study designed to investigate the development of chronic diseases, primarily diabetes and cardiovascular diseases and their risk factors over long-term follow-up. ELSA-Brasil enrolled and assessed 15,105 civil servants at selected universities and research institutions aged 35-74 y living in 6 cities (Salvador, Belo Horizonte, Rio de Janeiro, São Paulo, Vitoria, and Porto Alegre) located in the northeast (13.4% of participants), southeast (72.9% of participants), and south (13.7% of participants) regions of Brazil with baseline data collection from 2008 to 2010. Data analyzed were from this baseline examination. The research protocol was approved by the ethics committee of each institution, and all participants provided written consent.
Study participants
We excluded participants with known diabetes, cardiovascular disease, cancer, and other chronic diseases (stroke, emphysema, bronchitis, chronic obstructive pulmonary disease, cirrhosis, hepatitis, cardiac or bariatric surgery, rheumatic fever, Chagas disease, and thrombosis or emboli), those who used oral hypoglycemic medications or insulin, those who had low [#1298 kcal/d (2nd percentile)] or high [$6372 kcal/d (98th percentile)] reported energy intake, and women who had had gestational diabetes previously, which left 10,010 subjects for analysis.
Participants were interviewed, and standardized questionnaires provided information on demographic characteristics (age, sex, race, educational level, family income, occupational status, study site), family history of diabetes, smoking (current and previous), alcohol intake, physical activity, and menopausal status. Alcohol intake was estimated as the sum of ethanol (g/wk) of all beverages consumed. Physical activity variables were defined by using the leisure activity section of the International Physical Activity Questionnaire (IPAQ), long form, according to the IPAQ Guidelines for Data Processing and Analysis. Median values and IQRs were computed for walking, moderate-intensity activities, vigorous-intensity activities, and a combined total physical activity score. All continuous scores were expressed in metabolic equivalent minutes per week (10) .
Dietary assessment and dairy measurement
Dietary exposure was measured by a quantitative food-frequency questionnaire (FFQ) that was specific and validated in this population, which included 114 food items referent to the past 12 mo (11).
Questions on dairy products included milk (skimmed milk, lowfat milk, whole milk), yogurt (regular, low-fat), cheese (regular, low-fat), cheese spreads, cream cheese (regular, low-fat), ice cream, desserts made with milk (pudding, mousses), and butter. Mixed dishes and products for which the contribution of dairy was deemed negligible were not included in the derivation of our dairy intake estimates. Total dairy product intake was calculated as the sum of all dairy products reported in the dietary questionnaire. We computed servings per day for total dairy and the following subgroups of dairy (servings/d): full-fat and low-fat dairy, milk, cheese, yogurt, cheese spreads and cream cheese, desserts (dairy-based desserts), butter, and fermented dairy. The amounts per serving for each dairy food were 240 g for milk, 120 g for yogurt, 30 g for cheese and cream cheese, 80 g for ice cream, 50 g for dairy desserts, and 5 g for butter.
To assess possible mediation or confounding, we evaluated nutrients and intakes of nondairy food groups. To estimate the nutritional composition of the food items included in the FFQ we used the database of the Nutrition Data System for Research, University of Minnesota (12) . To determine the nutrients from the FFQ, we calculated the following: quantity of servings consumed per day 3 weight (standard portion in grams) 3 frequency of consumption 3 nutritional composition of the food serving. The coefficients for the daily equivalents used were as follows: 3 for .3 times/d, 2.5 for 2-3 times/d, 1 for once/d, 0.8 for 5-6 times/ wk, 0.4 for 2-4 times/wk, 0.1 for once/wk, 0.07 for 1-3 times/ mo, and 0 for never/almost never. When more than one food was listed in the same food item on the FFQ, the nutritional composition was weighted by the frequency that it appeared in food records in the validation study (11) . All brands and nutritional information labels were compared with food items available in the Nutrition Data System for Research. Those that were similar were chosen. The following nondairy food groups (g/d) were considered as possible confounders in our analyses: fruit, vegetables, whole and refined grains, nondairy sweets and desserts, processed and unprocessed red and white meat, eggs, beans, coffee, tea, juice, and sodas.
Clinical measurements
Anthropometric measurements (weight, height, and waist and hip circumferences) were obtained while participants were standing, dressed in a light uniform standardized for the study, and without shoes after an 8-to 15-h fast. We measured body weight to the nearest 0.1 kg with a calibrated balance (Toledo 2096PP) and height with a vertical stadiometer (Seca-SE-216) to the nearest 0.1 cm. Waist and hip circumferences were measured with a tape measure to the nearest 0.1 cm around the midpoint between the inferior border ribs and iliac crest for the waist and at the maximum protrusion of the buttocks for hips. BMI was calculated as weight in kilograms divided by height in meters squared.
A standard 75-g oral-glucose-tolerance test was administered to all participants who did not report a diagnosis or previous treatment of diabetes. Glucose was measured by a hexokinase method (ADVIA 1200 Chemistry; Siemens). Glycated hemoglobin (Hb A 1c ) was measured by using HPLC (Bio-Rad D-10 Dual Program Laboratories). Fasting insulin (FI) was measured with an ELISA (IMMULITE 2000; Siemens). HOMA-IR was calculated as glucose (mmol/L) 3 insulin (mU/L)/22.5.
We used 2 definitions to define newly diagnosed diabetes cases. The first was based on fasting glucose (FG) $126 mg/dL or 2-h postload glucose (PG) $200 mg/dL. The second definition also included Hb A 1c $6.5%. Final sample (n = 10,010) 
Multiple logistic regression was used to evaluate the association between dairy consumption and newly diagnosed diabetes. A linear trend was tested by modeling dairy servings per day as a continuous variable in the multivariable regression models.
We tested for potential mediation of the dairy associations by adding dairy components to the final models. The following dairy nutrients and components were evaluated as possible mediators:
animal Analyses were performed with the statistical package SPSS version 18, with the level of significance considered to be P , 0.05. Table 1 presents total dairy intake and specific dairy subgroups in servings per day for both the overall and final samples. Full-fat dairy intake was higher than low-fat dairy consumption. Measuring consumption in grams per day, milk made the largest contribution to dairy intake followed by fermented products (principally cheese and yogurt), with medians of 192 and 60 g/d, respectively. Table 2 summarizes baseline characteristics overall and by dairy consumption categories. These adults, with a mean age of 50.7 y, had an obesity prevalence of 20%. Dairy consumption was higher in women and in whites than in men or in other ethnic/race groups. Participants with higher dairy intakes tended to have lower alcohol consumption and higher levels of physical activity and of fruit, vegetable, whole-grain, and fish consumption.
RESULTS
As shown in Table 3 , we observed significant, graded, inverse associations between total dairy consumption and mean values of FG, PG, and Hb A 1c (model 2) after adjustment for demographic, 3 Adjusted for age and sex. 4 Adjusted for demographic characteristics [including age (continuous variable; y), sex, race, occupational status, education, family income (continuous variable), and study center], menopause, family history of diabetes, smoking status (current and previous), alcohol intake (g ethanol/d), physical activity (metabolic equivalent min/wk), calorie intake (kcal/d), and nondairy food groups (g/d; fruit, vegetables, whole grains, sodas, coffee, red meat overall and processed, eggs, nondairy desserts, and sweets).
5 Adjusted as for model 2 plus anthropometric variables (height and waist and hip circumferences). 6 Adjusted for demographic characteristics [including age (continuous variable; y), sex, race, occupational status, education, family income (continuous variable), and study center], menopause, family history of diabetes, smoking status (current and previous), alcohol intake (g ethanol/d), physical activity (metabolic equivalent min/wk), calorie intake (kcal/d), and nondairy food groups (g/d; vegetables, tea, sodas, processed red meat, eggs, nondairy desserts, and sweets).
lifestyle, and other dietary factors and also after further adjustment for anthropometric factors (model 3). We did not find a significant linear trend between total dairy consumption and adjusted mean FI. However, we did observe significant inverse associations between total dairy intake and adjusted means of PI and HOMA-IR ( Table 4) . subgroups. Dairy products that tend to be fermented (cheese, cream cheese, and yogurt) showed the strongest associations with glycemia. There was no significant association between subgroups of dairy consumption and measures of insulinemia (data not shown). We observed significant inverse associations between total dairy intake and previously undiagnosed diabetes ( Table 6) . Participants with reported intakes of .4 servings/ dairy per day had 29% (95% CI: 0.54, 0.95) lower odds of presenting previously undiagnosed diabetes when defined by FG or PG for diabetes criteria. The results were similar, albeit slightly weaker, when we added the Hb A 1c cutoff to the definition of diabetes. On the basis of tests for interaction and stratified analyses, the findings were consistent across categories of sex, race, obesity, and dairy fat content (reduced-fat vs. full-fat dairy; data not shown).
We evaluated several nutrients (animal protein; lactose; sugar; total fat; saturated fat; cholesterol; MUFAs; myristic, palmitic, stearic, and linoleic acids; vitamin D; calcium; magnesium; and potassium) as possible mediators of the association between dairy consumption and glycemia and insulinemia measures. The results suggested that myristic acid may explain the association between dairy product consumption and glycemia, insulin, and Hb A 1c concentrations. When myristic acid (% of energy) was added to the fully adjusted models, the adjusted linear coefficient for dairy consumption was markedly attenuated and no longer significant (Supplemental Table 1 ). The only other dairy component that demonstrated possible mediation was animal protein (% of energy), which, when added to the models, slightly attenuated the dairy and insulinemia associations (data not show).
DISCUSSION
In this free-living sample of middle-aged and older Brazilian men and women, we observed total dairy intake to be inversely associated with measures of glycemia and insulinemia, as well as with the presentation of newly diagnosed diabetes. Those who consumed .4 servings of dairy/d had 29% lower odds of undiagnosed diabetes than did those consuming ,1 serving of dairy/d. Fermented milk products, such as cheeses and yogurts, had the strongest inverse association with glycemia. SFAs found in dairy products, and particularly myristic acid, may be mediating the association between dairy intake and the glycemic outcomes.
The results of our study are consistent with other studies. Significant inverse dose-response associations were found for total dairy intake and the risk of T2D in a recent meta-analysis that included 17 cohort studies from the United States, Europe, Asia, and Australia with 426,055 participants and 26,976 cases of T2D. The summary RR for high compared with low intakes was 0.89 (95% CI: 0.82, 0.96). The inverse associations were attributed mainly to low-fat dairy, including low-fat or skim milk, and to cheese and yogurt (4) . In the present analysis, we found similar magnitudes and direction of the associations with diabetes for 2-4 servings of dairy/d and a stronger inverse association with diabetes for dairy intakes of .4 servings/d (OR: 0.71; 95% CI: 0.54, 0.95).
Another meta-analysis of randomized controlled studies in 1677 healthy adults that evaluated the effects of increased dairy consumption on cardiometabolic risk factors found that, for all studies combined, HOMA-IR was slightly improved with a high-dairy diet (20.94 units; 95% CI: 21.93, 0.04 units; P = 0.06). This association did not change significantly for studies stratified by body weight, duration of intervention, or high-fat vs. low-fat dairy. However, the results of this meta-analysis emphasized that most clinical trials were small and of modest quality (13) .
Some large prospective studies observed significant associations only between dairy consumption and risk of diabetes in subgroup analyses. The Coronary Artery Risk Development in Young Adults study showed inverse associations between total dairy consumption (and full-fat dairy products) and markers of glycemia among overweight and obese adults, whereas the findings were weaker for low-fat dairy intake (14) . Other subgroup analyses found inverse associations between cheese, yogurt, and fermented milk and diabetes risk (5, (15) (16) (17) . A pooled analysis of 7 cohort studies (254,892 participants and 19,082 cases) comparing high with low intakes of yogurt and T2D risk found an RR of 0.86 for high yogurt intake (95% CI: 0.75, 0.98). One of these prospective cohort studies, the European Prospective Investigation into Cancer and Nutrition-Interact Study, found cheese intake to have an inverse association with diabetes risk (HR: 0.88; 95% CI: 0.76, 1.02; P-trend = 0.01) (4) . Another more recent study observed the combined intake of fermented dairy products (cheese, yogurt, and thick fermented milk) to be inversely associated with diabetes risk (HR: 0.88; 95% CI: 0.78, 0.99; P-trend = 0.02) (17) .
The mechanistic factors linking fermented dairy intake with lower risk of T2D are unknown. It has been hypothesized that constituents of fermented dairy products promote gut microbial population shifts or influence inflammation and cardiovascular function via calcium-regulating peptides, calcitonin gene-related peptide (CGRP), or calcitonin (18) . Benefit may possibly be achieved through an increase in menaquinones, largely synthesized by probiotic bacteria, which have been inversely associated with diabetes risk in a large prospective study (19) . Recent studies support that fermentation-related mechanisms may be involved in the protective association (5, 16) .
Another area of interest with respect to mechanisms of action is the fatty acid profile of dairy products. Myristic acid (14:0) may be an activator of the conversion of a-linolenic acid (18:3n23) to DHA. In humans, a diet containing 1.2% of myristic acid over 5 wk significantly enhanced EPA and DHA, but when the consumption of myristic acid was further increased to 1.8% of energy, EPA, docosapentaenoic acid (22:5n23), and DHA decreased significantly (20) . These findings may explain why other researchers observed strong positive associations for both myristic and palmitic acids with markers of inflammation and metabolic risk factors only in the higher quartile of myristic acid (21) (22) (23) . Because these pathways may be upstream of insulin sensitivity and glycemia, it is plausible that moderate consumption of myristic acid may have beneficial effects on diabetes and cardiovascular disease, whereas high consumption may not. Indeed, other studies suggested that other SFAs in milk may confer protection against diabetes (3, (24) (25) (26) (27) . Animal and cell model studies support a positive effect of dairy-rich diets on metabolic and inflammatory factors relevant to T2D and insulin resistance (18) .
Micronutrients found in dairy, such as calcium, potassium, and magnesium, may contribute to lower the risk of diabetes and cardiovascular diseases (28, 29) . However, adjustment for these nutrients did not materially change the associations for dairy intake and the glycemic outcomes in our study. In addition, the low glycemic load of most dairy products, resulting from their lactose and high protein and fat content, may enhance satiety, thereby helping to control appetite and energy balance as well as directly and indirectly reducing blood sugar and insulin concentrations (14, 30) . Finally, it has been hypothesized that increasing dairy proteins may impart glucose-regulating properties by triggering gut hormones, particularly incretins, and increasing gut motility, thereby improving postmeal glycemia (18, 31) .
A major strength of this study is the direct measurements of the outcomes, because newly diagnosed cases of diabetes were determined by a standardized 75-g oral-glucose-tolerance test. Because of the observational nature of our study, it is possible that our findings resulted from residual confounding, despite extensive adjustment for other dietary variables and risk factors for diabetes. Although the FFQ has been widely used in epidemiologic studies, this method has limitations. The main limitation of this subjective retrospective method for dietary assessment is the dependence on participant memory, which could lead to under-or over-reporting of food intake.
Although cross-sectional in nature, these findings suggest that greater dairy intake may improve glycemia and prevent diabetes, independent of obesity status, in Brazilian men and women. The findings are relatively strong, follow a dose-response linear pattern, are biologically plausible, and are consistent with the literature. The findings of this study may have public health implications, given the decline in dairy intake and the increasing prevalence of diabetes in Brazil. More studies are required to evaluate possible mechanisms and causality.
